Carmot Therapeutics Company
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases. They employ their patented technology, chemotype evolution, to address the fundamental causes of disease and speed the discovery of disease-modifying therapies.
Funding Status:
private
Employee Number:
11-50
Last Funding Date:
2023-05-25
Headquarters:
Berkeley,California,United States,North America
Total Funding:
384846101
Founded Date:
2008-01-01
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
M&A
Funding Total Value:
384846101
Last Funding Total Usd:
150000000
Last Funding Total Currency:
USD
Last Funding Total Value:
150000000
Founders:
Daniel A. Erlanson,Stig Hansen
Phone Number:
5105279251